All insights
Cell therapy laboratory environment, evoking the advanced therapy medicinal product supply chain CellConnect is building.

Marino Software to build breakthrough infrastructure for national cell therapy hub "CellConnect"

Marino Software has joined the DTIF-funded CellConnect consortium to deliver the critical digital infrastructure for a first-of-its-kind Advanced Therapy Medicinal Product (ATMP) supply chain in Ireland.

Ed Melvin
Chief Strategy Officer

Cara Ludlow, COO Marino Software, Dr. Ruth Levey, Principal Researcher from University of Galway, and Paul Loftus, R&D Manager, HiTech Health, the CellConnect consortium members. CellConnect is a DTIF-funded cell therapy treatment platform that aims to address critical global challenges in the manufacture, distribution, and delivery of therapeutic cells.

DUBLIN, IRELAND, 15 February 2026. Marino Software, a leading Irish provider of compliant cloud, mobile and AI solutions based on the DCU:Innovate campus in Glasnevin, Dublin, today announced it has joined the CellConnect consortium, to deliver the critical digital infrastructure for a first-of-its-kind Advanced Therapy Medicinal Product (ATMP) supply chain in Ireland.

Funded by the Irish Government’s €500 million Disruptive Technologies Innovation Fund (DTIF), the CellConnect project represents a €6.58 million investment in national health infrastructure. Marino Software joins existing partners HiTech Health and the University of Galway to replace manual, paper-based processes with a high-security, cloud-native platform designed to manage the “just-in-time” delivery of life-saving cell and gene therapies.

Software made human

This partnership aligns with Marino Software’s mission of “software, made human,” focusing on utilising technology to solve citizen-critical challenges. Joining the CellConnect consortium reinforces Marino’s status as a proven digitalisation partner for high-compliance sectors.

“Our vision is to make lives better through software that is as secure as it is intuitive. CellConnect is more than a technical challenge; it is about building breakthrough infrastructure that ensures patients can access transformative treatments. We are bringing our deep expertise in high-value, secure systems, from banking to healthcare and public transport, to ensure Ireland leads the global landscape in ATMP manufacturing and management.”

Cara Ludlow, COO, Marino Software

Breakthrough national infrastructure

Current ATMP manufacturing faces significant bottlenecks, particularly in sourcing starting materials like lipoaspirates, which must be processed within 48 hours. Marino Software will develop the CellConnect Cloud, a secure, GxP-compliant end-to-end traceability platform that provides:

  • Electronic batch records. Moving from paper-based systems to secure digital logs.
  • Real-time monitoring. Integrating sensor data to monitor cell viability during transport.
  • Global exportability. Creating a standards-based architecture that allows Irish-developed therapies to be scaled internationally.

“Digitalisation is no longer optional for ATMP manufacturing, it is foundational. End-to-end digital traceability ensures that every process step, every decision, and every test is visible, auditable, and controlled. This level of transparency is essential not only for regulatory compliance, but for patient safety and scalable, sustainable delivery of advanced therapies. So it is fantastic to have Marino Software partnering with us to deliver this essential component.”

Paul Loftus, R&D Manager, HiTech Health and Project Manager on CellConnect

By solving current supply chain bottlenecks, such as the requirement to process human tissue within 48 hours of collection, CellConnect provides a robust, “just-in-time” digital and physical infrastructure. This breakthrough infrastructure is designed to reduce treatment costs and position Ireland as a global centre of excellence for the next generation of advanced therapy medicinal products (ATMPs).

“At the University of Galway, our multidisciplinary team is developing the preservation and controlled transport systems required to safely manage starting materials and living cell therapies from collection through to manufacture and delivery. By integrating this work with Marino’s secure digital platform, we are establishing a fully traceable, quality-assured infrastructure that strengthens Ireland’s capacity to reliably scale advanced therapy production.”

Dr Ruth Levey, Lead Researcher, University of Galway

The University of Galway team is led by Prof. Garry Duffy and Dr. Ruth Levey, with Dr. Ruth Tarpey playing a key role in design optimisation and translational integration across the project.

Proven excellence in high-compliance sectors

Based at the DCU:Innovate Hub, Marino Software is ISO 27001, 27017, and 9001 accredited. The company has a storied history of delivering high-stakes digital tools, including:

  • Healthtech. Using advanced machine learning to design and develop ReVoice, an app for those with Motor Neurone Disease, and partnering with the Rotunda Hospital on Thrombocalc, a VTE risk assessment tool.
  • Financial services. A key digital enablement partner for PTSB.
  • Public infrastructure. Flagship solutions for Met Éireann, Iarnród Éireann, RTÉ and Bus Éireann.

About the Disruptive Technologies Innovation Fund (DTIF)

The DTIF is a challenge-based fund established under the National Development Plan (NDP) to support collaborative research and drive the development of technologies that will change how we live and work.

Let's talk.

Remote, on-site, or in Glasnevin, Dublin. We start with your customer and work back. You'll leave with a clearer picture of the next move, whether or not it's with us.